Amicus Brief

Schering-Plough Ltd v. European Commission and EMEA

Published: December 5, 2003

Court

European Court of First Instance

Our Position

There should be no prohibition on the use of one trademark for the pharmaceutical form of a medicinal product and a second trademark for a dosage form of, or delivery device for, the product.

Outcome

Action dismissed by the court without decision on the merits.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.